Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


03.06.2024

2 Acta Haematol
1 Am J Clin Pathol
3 Am J Hematol
2 Ann Hematol
4 Blood
1 BMC Cancer
2 Cancer
1 Cancer Chemother Pharmacol
2 Int J Hematol
2 Leuk Lymphoma
1 Leuk Res
1 Leukemia
1 N Engl J Med


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. ZENG X, Liu K, Xu R, Zhang L, et al
    TES and SLC40A1 as potential biomarkers for predicting survival in T-cell acute lymphoblastic leukemia.
    Acta Haematol. 2024 May 28. doi: 10.1159/000539435.
    PubMed         Abstract available

  2. MOLICA S, Rossi M, Allsup D
    Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide.
    Acta Haematol. 2024;147:257-259.
    PubMed         Abstract available


    Am J Clin Pathol

  3. SAMEETA F, Wang SA, Tang Z, Khoury JD, et al
    Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement.
    Am J Clin Pathol. 2024 May 27:aqae060. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  4. VERONESE L, Bensaber H, Dannus LT, Giannone G, et al
    Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogenetique Hematologique (GFCH)/French Innovative Leukemia Organization (FILO) study.
    Am J Hematol. 2024 May 30. doi: 10.1002/ajh.27384.
    PubMed        

  5. OTHMAN T, Koller P, Tsai NC, Yang D, et al
    Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Am J Hematol. 2024 May 28. doi: 10.1002/ajh.27378.
    PubMed         Abstract available

  6. OTHMAN T, Li S, Zhang J, Pourhassan H, et al
    Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Am J Hematol. 2024 May 27. doi: 10.1002/ajh.27365.
    PubMed         Abstract available


    Ann Hematol

  7. LI Y, Zhang Q, Shao H
    Chemotherapy vs. "TKI + immunotherapy" in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene.
    Ann Hematol. 2024 May 29. doi: 10.1007/s00277-024-05816.
    PubMed        

  8. WANG Q, Hu Y, Gao L, Zhang S, et al
    Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases.
    Ann Hematol. 2024 May 28. doi: 10.1007/s00277-024-05810.
    PubMed         Abstract available


    Blood

  9. ONIDA F, Gagelmann N, Chalandon Y, Kobbe G, et al
    Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
    Blood. 2024;143:2227-2244.
    PubMed         Abstract available

  10. KANG YA
    Awakening your innate power to combat AML.
    Blood. 2024;143:2223-2224.
    PubMed        

  11. KOURY LCA, Kim HT, Undurraga MS, Navarro-Cabrera JR, et al
    Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
    Blood. 2024 May 28:blood.2024023890. doi: 10.1182/blood.2024023890.
    PubMed         Abstract available

  12. HALL T, Gurbuxani S, Crispino JD
    Malignant progression of preleukemic disorders.
    Blood. 2024;143:2245-2255.
    PubMed         Abstract available


    BMC Cancer

  13. CASILE M, Albrand G, Lebecque B, Besombes J, et al
    Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial).
    BMC Cancer. 2024;24:661.
    PubMed         Abstract available


    Cancer

  14. SENAPATI J, Kantarjian HM, Bazinet A, Reville P, et al
    Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation.
    Cancer. 2024 May 29. doi: 10.1002/cncr.35388.
    PubMed         Abstract available

  15. HADDAD FG, Sasaki K, Nasr L, Short NJ, et al
    Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase.
    Cancer. 2024 May 28. doi: 10.1002/cncr.35384.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  16. GAIETTO A, Panetta JC, Pauley JL, Relling MV, et al
    Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.
    Cancer Chemother Pharmacol. 2024;93:617-625.
    PubMed         Abstract available


    Int J Hematol

  17. GONZALEZ-MANCERA MS, Lopategui J, Hoffman D, Kitahara S, et al
    B-cell prolymphocytic leukemia: an enduring bona fide entity.
    Int J Hematol. 2024 May 26. doi: 10.1007/s12185-024-03774.
    PubMed         Abstract available

  18. ARAI S, Tachibana T, Izumi A, Takeda T, et al
    WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
    Int J Hematol. 2024 May 25. doi: 10.1007/s12185-024-03795.
    PubMed         Abstract available


    Leuk Lymphoma

  19. FANG J, Bosma G, Aisner D, McMahon C, et al
    White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia.
    Leuk Lymphoma. 2024;65:800-807.
    PubMed         Abstract available

  20. MURPHY L, Siegele B, Carstens B, Hartman L, et al
    A pediatric case of KMT2A-rearranged B-lymphoblastic lymphoma treated with high-risk therapy.
    Leuk Lymphoma. 2024 Feb 19:1-5. doi: 10.1080/10428194.2024.2315159.
    PubMed        


    Leuk Res

  21. PANDA T, Rainchwar S, Singh R, Singh A, et al
    Real world outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in adolescents and adults treated with intensive regimes.
    Leuk Res. 2024;141:107506.
    PubMed         Abstract available


    Leukemia

  22. ZHU R, Shirley CM, Chu SH, Li L, et al
    Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.
    Leukemia. 2024 May 29. doi: 10.1038/s41375-024-02292.
    PubMed         Abstract available


    N Engl J Med

  23. HOCHHAUS A, Wang J, Kim DW, Kim DDH, et al
    Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
    N Engl J Med. 2024 May 31. doi: 10.1056/NEJMoa2400858.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.